ALX ONCOLOGY HOLDINGS INC·4

Sep 12, 4:24 PM ET

Lettmann Jason 4

4 · ALX ONCOLOGY HOLDINGS INC · Filed Sep 12, 2023

Insider Transaction Report

Form 4
Period: 2023-09-08
Lettmann Jason
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-09-08+1,200,0001,200,000 total
    Exercise: $4.92Exp: 2033-09-07Common Stock (1,200,000 underlying)
Footnotes (1)
  • [F1]One-fourth of the shares subject to the option vest on September 5, 2024 and 1/48th of the shares vest monthly thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION